articleNature MedicineFeb 12, 2012Closed access

RET, ROS1 and ALK fusions in lung cancer

Japanese Foundation For Cancer Research · Jichi Medical University · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,326
total citations
FWCI
112.26
Percentile
100%
References
19
Citations per year

Authors

16

Topics & keywords

Keywords
  • ROS1
  • Anaplastic lymphoma kinase
  • Cancer research
  • Adenocarcinoma
  • Oncogene
  • Lung cancer
  • Receptor tyrosine kinase
  • Tyrosine kinase
UN Sustainable Development Goals
  • No poverty
No related works found for this paper.

Funding